Capecitabine 1000 mg Dispersible Tablets

Get a Price/Quote

MOQ : 100 Packs

Capecitabine 1000 mg Dispersible Tablets Specification

Salt Composition
Capecitabine 1000 mg

Dosage Form
Dispersible Tablets

Indication
Used in the treatment of metastatic breast and colorectal cancer

Feature
Dispersible form for ease of administration

Ingredients
Capecitabine and excipients

Application

Physical Color/Texture
White to off-white, round, beveled-edge uncoated tablets

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from moisture and light

Shelf Life
24 months

Packing
Box of 10 x 1 tablets (10 tablets per box)

Brand Name
CAPETAB

Prescription Status
Prescription only (Rx)

Contraindication
Contraindicated in patients with severe renal impairment

Administration Route
Oral

Market Availability
Available in select oncology clinics and hospitals

Regulatory Status
Manufactured under GMP compliance

Excipients
Contains mannitol, crospovidone, magnesium stearate, and other pharmaceutical excipients

Instructions for Use
Tablet to be dispersed in water before administration

Capecitabine 1000 mg Dispersible Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Capecitabine 1000 mg Dispersible Tablets

CAPETAB Capecitabine 1000 mg Dispersible Tablets are a cost-effective and top-tier solution for oncologists aiming to provide heroic anti-cancer therapy. Each tablet is meticulously formulated with Capecitabine and pharmaceutical excipients such as mannitol and magnesium stearate, ensuring optimal patient outcomes. This virtuoso dispersible form enhances ease of administration-simply disperse in water for rapid dosing. Capitalise on CAPETAB's reliability, manufactured under GMP compliance and available via select oncology clinics across India, designed for the treatment of metastatic breast and colorectal cancer. Sale is limited to prescription only.

Versatile Application for Oncology Settings

Capecitabine 1000 mg Dispersible Tablets are expertly designed for oncological applications, specifically in chemotherapy and anti-cancer treatment protocols. Their surface of application is internal-administered orally-ensuring direct action via the digestive tract. The application media is water; the tablet is simply dispersed before intake, making administration straightforward for both patients and healthcare professionals. This ease of use enhances treatment adherence, especially for those with swallowing difficulties.

Comprehensive Packaging and Export Solutions

CAPETAB is securely packed in boxes containing 10 x 1 tablets, guaranteeing stability throughout the logistics process. With a shelf life of 24 months and storage guidance to protect from moisture and light, product integrity is maintained until administration. Quotations are available upon request for bulk orders, and shipping is streamlined for both local and international oncology markets. Our sample policy and export logistics cater to main markets across India and select overseas destinations.

FAQ's of Capecitabine 1000 mg Dispersible Tablets:

Q: How should Capecitabine 1000 mg Dispersible Tablets be administered?

A: The tablet must be dispersed in water before administration. It should not be swallowed whole; follow your physician's instructions for correct dosing.

Q: What is the main therapeutic benefit of CAPETAB?

A: CAPETAB is used in the treatment of metastatic breast and colorectal cancer, providing a convenient, dispersible oral option for chemotherapy regimens.